Allison Fitzgerald, MD, PhD/X
Dec 19, 2025, 11:34
Arterial or Atypical Clots? Think APLS, PNH, and MPN
Allison Fitzgerald, Heme/Onc Fellow at Dana-Farber, posted on X:
”Today I learned that while clots in veins can be caused by all sorts of things, clots in arteries are usually caused by cancer or anti-phospholipid syndrome (APLS).
Adding paroxysmal nocturnal hemoglobinuria and myeloproliferative neoplasms (which is a subtype of cancer, but more specific, I suppose) to this list.
So clots in arterial or weird venous places:
– APLS
– PNH
– MPN
– HIT
– hyperhomocysteinemia”
Stay updated with Hemostasis Today.
Allison Fitzgerald
Antiphospholipid Syndrome
APLS
APS
Arterial thrombosis
Blood Clot
Cancer Associated Thrombosis
Dana-Farber
Health
Hematology
Hemostasis
Hemostasis Today
heparin-induced thrombocytopenia
HIT
Hyperhomocysteinemia
Medicine
MPN
myeloproliferative neoplasms
paroxysmal nocturnal hemoglobinuria
PNH
thrombosis
-
Jun 26, 2026, 10:19Rytis Masiliūnas: Atrial Fibrillation and Stroke Care Disparities Across the Baltic Region
-
Jun 26, 2026, 10:11Kayla Kilani: First-Ever CT Perfusion Scan Performed Inside a Mobile Stroke Unit
-
Jun 26, 2026, 07:38Baraa Nassar: High Clinical Suspicion Is Essential for Early Diagnosis of CVST
-
Jun 26, 2026, 07:10Saleh Shamse Basha: Why APTT Alone Can Be Misleading During UFH Monitoring
-
Jun 26, 2026, 06:01Nicolas Hubacz: A Sharper Look at the Brain’s Vascular Landscape
-
Jun 26, 2026, 05:57Ayse Bahar Keleşoğlu Dinçer: New Insights into Antiphospholipid Syndrome Classification and Recurrent Thrombosis Risk
-
Jun 26, 2026, 05:55Shinya Goto: How Newton’s Laws Shape Platelet Function
-
Jun 26, 2026, 05:50Andrew Emad: Five Years of Partnership, Innovation, and Impact at Africa Health ExCon 2026
-
Jun 26, 2026, 05:48Regan Bucciol: The Emerging Role of Erythrocytes in Thrombosis